A 60-year-old woman with severe obesity had an unusual opportunity: electrodes implanted in her brain to monitor cravings, combined with a prescription for tirzepatide (sold as Mounjaro and Zepbound). What researchers saw in her brain activity over five months offers a rare window into how these drugs actually work — and why they might not be the complete answer we're hoping for.
Before tirzepatide, her brain was in constant noise. Food preoccupation — the relentless mental static of thinking about eating — dominated her thoughts. Scans showed intense activity in the nucleus accumbens, the brain's reward center, the same region that lights up with craving and impulse.
Then she started the medication. Within weeks, something shifted. The food noise stopped. Her obsessive thoughts about eating vanished. On the brain scans, that reward center went quiet. For about five months, she experienced something she hadn't felt in years: freedom from the constant pull toward food.
We're a new kind of news feed.
Regular news is designed to drain you. We're a non-profit built to restore you. Every story we publish is scored for impact, progress, and hope.
Start Your News Detox"This study offers major insights into how these drugs may work inside the brain," said Casey H. Halpern, the senior researcher. But here's where the story gets complicated.
The Effect Wore Off
After five months, the brain activity came roaring back. The nucleus accumbens lit up again. The food preoccupation returned with it. The medication, which had felt like a reset button on her cravings, had stopped working — or at least stopped working the same way.
This matters because tirzepatide wasn't designed for this. It was built for Type 2 diabetes and weight management, and it does both well. But the emerging evidence suggests it might help with binge eating and food obsession too — except the effect doesn't stick. "They might be useful to manage food preoccupation and binge eating, but not in their current form," said Kelly Allison, one of the researchers.
The woman in this case had already tried numerous treatments before the brain surgery and medication. She knew what it meant to be trapped in a cycle of craving and loss of control. For five months, she wasn't. Then she was again.
What this case study reveals is both hopeful and honest. These medications clearly do something in the brain — they're not placebos, and they're not just suppressing appetite mechanically. They're changing the reward signals themselves. But understanding how they work is different from understanding why the effect fades, or how to make it last.
The research suggests the next generation of treatments needs to be more targeted. Not just medications that happen to quiet the reward center, but drugs specifically designed to address the impulse-control patterns that drive binge eating and food obsession. That's harder to build than it sounds, but this patient's brain scans have given researchers a clearer map of what they're trying to fix.
